Search Results

You are looking at 41 - 50 of 57 items for :

  • "pituitary adenoma" x
Clear All
Open access

Lijin Ji, Na Yi, Qi Zhang, Shuo Zhang, Xiaoxia Liu, Hongli Shi and Bin Lu

. Diagnosis and treatment of pituitary adenomas: a review . JAMA 2017 317 516 – 524 . ( https://doi.org/10.1001/jama.2016.19699 ) 28170483 10.1001/jama.2016.19699 4 Vilar L Naves LA Casulari LA Azevedo MF Albuquerque JL Serfaty FM Pinho Barbosa FR de

Open access

Eeva M Ryhänen, Ilkka Heiskanen, Harri Sintonen, Matti J Välimäki, Risto P Roine and Camilla Schalin-Jäntti

pituitary adenomas having surgery as primary treatment . Clinical Endocrinology 2015 82 412 – 421 . ( doi:10.1111/cen.12550 ). 12 Kluger N Matikainen N Sintonen H Ranki A Roine RP Schalin-Jäntti C . Impaired health-related quality of life

Open access

Marco Marino, Valentina Cirello, Valentina Gnarini, Carla Colombo, Elisa Pignatti, Livio Casarini, Chiara Diazzi, Vincenzo Rochira, Katia Cioni, Bruno Madeo, Cesare Carani, Manuela Simoni and Laura Fugazzola

Z Liu J Liu Y . Pituitary tumor transforming gene-1 haplotypes and risk of pituitary adenoma: a case–control study . BMC Medical Genetics 2011 12 44 . ( doi:10.1186/1471-2350-12-44 ). 16 Wondergem B Zhang Z Huang D Ong CK Koeman

Open access

Enrique Soto-Pedre, Paul J Newey, John S Bevan and Graham P Leese

visible pituitary adenomas and/or diagnosis of hyperprolactinaemia followed for 14 years but no increased risk of breast cancer was observed ( 12 ). However, several large case-controlled and population-based cohort studies have failed to show any

Open access

Mikkel Andreassen, Anders Juul, Ulla Feldt-Rasmussen and Niels Jørgensen

supporting sufficient bioactivity. One previous study has investigated FSH bioactivity in male patients with non-functioning pituitary adenomas and found unchanged in vitro FSH bioactivity. By contrast clinically relevant changes in the bioactivity of

Open access

Elizaveta Mamedova, Natalya Mokrysheva, Evgeny Vasilyev, Vasily Petrov, Ekaterina Pigarova, Sergey Kuznetsov, Nikolay Kuznetsov, Liudmila Rozhinskaya, Galina Melnichenko, Ivan Dedov and Anatoly Tiulpakov

after surgical treatment and seven patients had pituitary adenomas, neuroendocrine tumors or other tumors diagnosed after PHPT. Nobody had a histological diagnosis of parathyroid carcinoma or atypical parathyroid adenoma. Table 4 Clinical

Open access

Johan Verhelst, Anders F Mattsson, Cecilia Camacho-Hübner, Anton Luger and Roger Abs

Bengtsson BÅ Johannsson G Nilsson AG. Life expectancy in patients with pituitary adenoma receiving growth hormone replacement . European Journal of Endocrinology 2017 176 67 – 75 . ( https://doi.org/10.1530/EJE-16-0450 ) 27770012 10.1530/EJE

Open access

Jingya Zhou, Meng Zhang, Lin Lu, Xiaopeng Guo, Lu Gao, Weigang Yan, Haiyu Pang, Yi Wang and Bing Xing

 CD- or ACTH-secreting pituitary adenoma or pituitary dependent CS E24.0/(D35.2 + E24.9) E24.001/(D35.2 + E24.901)  EAS E24.3 E24.301 ACTH-independent CS  ACA D35.0 + (E24.8/E24.9) D35.001 + (E24.801/E24

Open access

K E Lines, R P Vas Nunes, M Frost, C J Yates, M Stevenson and R V Thakker

-0240 ) 23 Walls GV Lemos MC Javid M Bazan-Peregrino M Jeyabalan J Reed AA Harding B Tyler DJ Stuckey DJ Piret S MEN1 gene replacement therapy reduces proliferation rates in a mouse model of pituitary adenomas . Cancer

Open access

Alberto Giacinto Ambrogio, Massimiliano Andrioli, Martina De Martin, Francesco Cavagnini and Francesca Pecori Giraldi

-secreting cells derived from a rapidly growing pituitary adenoma . Brain Tumor Pathology 2000 17 133 – 138 . ( doi:10.1007/BF02484284 ) 10.1007/BF02484284 11310920 19 Leal Cerro A Martin Rodriguez JF Ibañez-Costa A Madrazo-Atutxa AM